Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Cash from Investing Activities (2017 - 2025)

Selectis Health's Cash from Investing Activities history spans 14 years, with the latest figure at -$4233.0 for Q3 2025.

  • For Q3 2025, Cash from Investing Activities fell 766.61% year-over-year to -$4233.0; the TTM value through Sep 2025 reached -$396824.0, down 116.15%, while the annual FY2024 figure was $2.4 million, 8315.86% up from the prior year.
  • Cash from Investing Activities for Q3 2025 was -$4233.0 at Selectis Health, up from -$163515.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $2.6 million in Q2 2024 and bottomed at -$239679.0 in Q3 2022.
  • The 5-year median for Cash from Investing Activities is -$34706.5 (2022), against an average of $71667.1.
  • The largest annual shift saw Cash from Investing Activities skyrocketed 518.79% in 2022 before it plummeted 766.61% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$25886.0 in 2021, then surged by 518.79% to $108408.0 in 2022, then plummeted by 101.77% to -$1914.0 in 2023, then plummeted by 413.9% to -$9836.0 in 2024, then soared by 56.96% to -$4233.0 in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Cash from Investing Activities are -$4233.0 (Q3 2025), -$163515.0 (Q2 2025), and -$219240.0 (Q1 2025).